CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Genentech, Inc.

Explore the PTAB proceeding IPR2016-01693 filed by Mylan Pharmaceuticals Inc. et al. on 2016-08-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-01693

Filing Date

2016-08-30

Accorded Filing Date

2016-08-30

Institution Decision Date

β€”

Last Modified Date

β€”

Proceeding Type

IPR

Termination Date

2017-03-10

Trial Status

Terminated-Settled

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 08146206
Respondent Patent Number 6407213
Legal Expiration Date
2020-06-30 Expired (Term Ended)
Patent Term Adjustment (PTA) +2937 Days Awarded
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Tech Center TC 1600 (Biotechnology & Organic Chemistry)

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 (Biotechnology & Organic Chemistry)

Decisions Rendered

1 Total

Proceeding Status

Terminated-Settled

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Termination 2017-03-10
Termination Decision Document
37 CFR 42.72, 37 CFR 42.74, 35 USC 317

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 8 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (8 found):
PTAB: 8
USPTO PTAB Trial 2017-09-29
IPR2017-02139

Samsung Bioepis Co., Ltd. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-08-31
IPR2017-02032

Boehringer Ingelheim Pharmaceuticals, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated
USPTO PTAB Trial 2017-08-31
IPR2017-02031

Boehringer Ingelheim Pharmaceuticals, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated
USPTO PTAB Trial 2017-05-25
IPR2017-01489

Pfizer, Inc. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-05-25
IPR2017-01488

Pfizer, Inc. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-05-08
IPR2017-01374

Celltrion Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-05-08
IPR2017-01373

Celltrion Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-08-30
IPR2016-01694

Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

100
26

Notice of Refund Paper

2017-04-05 FILING PARTY: BOARD
25

MYLAN PHARMACEUTICALS INC.'S REQUEST FOR REFUND OF POST-INSTITUTION FEE AND EXCESS CLAIM FEES FOR INTER PARTES REVIEW OF U.S. PATENT NO. 6,407,213 Paper

2017-03-13 FILING PARTY: PETITIONER
24

Termination Decision Document Paper

2017-03-10 FILING PARTY: BOARD
21

Joint Motion to Terminate Proceeding Pursuant to 35 U.S.C. 317(a) Paper

2017-03-07 FILING PARTY: PETITIONER
23

Petitioners Updated Exhibit List Paper

2017-03-07 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc